0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Forecasting the Long-Term Economic Trajectory of Advanced Therapeutics Manufacturing: A Decisive Look at Capacity and Capital InvestmentThe long-term economic forecast for the advanced therapeutics manufacturing sector is overwhelmingly positive, driven by the expanding clinical success of monoclonal antibodies, the robust pipeline of cell and gene therapies, and the emergence of RNA-based medicines. This optimism, however, is tethered to the critical bottleneck of global manufacturing capacity, particularly for complex...0 Commentaires 0 Parts 696 Vue 0 Aperçu
-
How Is the Essential Thrombocytosis Treatment Market Advancing Rare Blood Disorder Care?Detailed Analysis of Executive Summary Essential Thrombocytosis Treatment Market Size and Share CAGR Value The global essential thrombocytosis treatment market size was valued at USD 968.50 Million in 2025 and is expected to reach USD 1509.03 Million by 2033, at a CAGR of 5.70% during the forecast period The Essential Thrombocytosis Treatment report provides market shares at global...0 Commentaires 0 Parts 191 Vue 0 Aperçu
-
Nucleic Acid Therapeutics CDMO Market to Reach $4.9B by 2031: Inside the 11.09% CAGR SurgeMarket Overview The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031). The global Nucleic Acid Therapeutics CDMO market continues to evolve rapidly, driven by shifting consumer trends, rising...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...0 Commentaires 0 Parts 78 Vue 0 Aperçu